<DOC>
	<DOC>NCT01773655</DOC>
	<brief_summary>The goal of this protocol is to determine the prevalence of somatic and germline mutations in BAP1 (BRCA associated protein-1) among patients with mesothelioma , choroidal nevus, primary uveal melanoma (UM), or metastatic UM seen at our institution.</brief_summary>
	<brief_title>Clinical and Histopathologic Characteristics of BAP1 Mutations</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Carcinoma, Renal Cell</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Uveal Neoplasms</mesh_term>
	<criteria>All consents: &gt; or = to 18 years of age Ability to provide informed consent Consent 1: Mesothelioma Histologically proven diagnosis of Mesothelioma OR Choroidal nevus Diagnosis of choroidal nevus by direct examination and/or ultrasound/optical coherence tomography and possibly fluorescein angiography OR Primary uveal melanoma Diagnosis of uveal melanoma by direct examination and/or ultrasound/optical coherence tomography and possibly fluorescein angiography Consent 2: Mesothelioma Histologically proven diagnosis of Mesothelioma AND BAP1 mutation or loss of expression identified in tumor sample OR one of the following: Age&lt;50 at diagnosis No history of asbestos exposure Personal history of choroidal nevus, uveal melanoma, melanoma, renal cell carcinoma, or cholangiocarcinoma Family history of choroidal nevus, uveal melanoma, mesothelioma, renal cell carcinoma, or cholangiocarcinoma History of malignancy in more than two firstdegree relatives OR Choroidal nevus Diagnosis of choroidal nevus by direct examination and/or ultrasound/optical coherence tomography and possibly fluorescein angiography AND one of the following: More than one clinical risk factor, which may include: orange pigment, thickness &gt; 1 &lt; 2.5mm Personal history of uveal melanoma, skin melanoma, mesothelioma renal cell carcinoma, or cholangiocarcinoma Family history of choroidal nevus, uveal melanoma, mesothelioma renal cell carcinoma, or cholangiocarcinoma OR Primary uveal melanoma Diagnosis of uveal melanoma by direct examination and/or ultrasound/optical coherence tomography and possibly fluorescein angiography AND one of the following: Personal history of uveal melanoma, skin melanoma, mesothelioma, renal cell carcinoma, or cholangiocarcinoma Family history of choroidal nevus, uveal melanoma, mesothelioma, renal cell carcinoma, or cholangiocarcinoma History of malignancy in more than two firstdegree relatives OR Metastatic uveal melanoma Histologically proven diagnosis of metastatic uveal melanoma AND BAP1 mutation or loss of expression identified in tumor sample OR one of the following: Personal history of uveal melanoma, skin melanoma, mesothelioma renal cell carcinoma, or cholangiocarcinoma Family history of choroidal nevus, uveal melanoma, mesothelioma renal cell carcinoma, or cholangiocarcinoma History of malignancy in more than two firstdegree relatives Consent 3: Relative of patient with germline BAP1 mutation identified through identified testing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>somatic</keyword>
	<keyword>germline</keyword>
	<keyword>mutations</keyword>
	<keyword>BAP1 (BRCA associated protein-1)</keyword>
	<keyword>12-235</keyword>
</DOC>